Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 492

1.

A Polygenic Lipodystrophy Genetic Risk Score Characterizes Risk Independent of BMI in the Diabetes Prevention Program.

Srinivasan S, Jablonski KA, Knowler WC, Dagogo-Jack S, E Kahn S, Boyko EJ, Bray GA, Horton ES, Hivert MF, Goldberg R, Chen L, Mercader J, Harden M, Florez JC; Diabetes Prevention Program Research Group.

J Endocr Soc. 2019 Jun 24;3(9):1663-1677. doi: 10.1210/js.2019-00069. eCollection 2019 Sep 1.

2.

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline.

Rosenzweig JL, Bakris GL, Berglund LF, Hivert MF, Horton ES, Kalyani RR, Murad MH, Vergès BL.

J Clin Endocrinol Metab. 2019 Jul 31. pii: jc.2019-01338. doi: 10.1210/jc.2019-01338. [Epub ahead of print]

PMID:
31365087
3.

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Perreault L, Pan Q, Schroeder EB, Kalyani RR, Bray GA, Dagogo-Jack S, White NH, Goldberg RB, Kahn SE, Knowler WC, Mathioudakis N, Dabelea D; Diabetes Prevention Program Research Group.

Diabetes Care. 2019 Sep;42(9):1809-1815. doi: 10.2337/dc19-0244. Epub 2019 Jul 18.

PMID:
31320445
4.

Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease.

Cardenas A, Hivert MF, Gold DR, Hauser R, Kleinman KP, Lin PD, Fleisch AF, Calafat AM, Ye X, Webster TF, Horton ES, Oken E.

Diabetes Care. 2019 Sep;42(9):1824-1832. doi: 10.2337/dc18-2254. Epub 2019 Jul 11.

PMID:
31296647
5.

Concurrent Opioid and Alcohol Use Among Women Who Become Pregnant: Historical, Current, and Future Perspectives.

Klaman SL, Andringa K, Horton E, Jones HE.

Subst Abuse. 2019 May 30;13:1178221819852637. doi: 10.1177/1178221819852637. eCollection 2019.

6.

Mesenchymal stromal cell activation by breast cancer secretomes in bioengineered 3D microenvironments.

Blache U, Horton ER, Xia T, Schoof EM, Blicher LH, Schönenberger A, Snedeker JG, Martin I, Erler JT, Ehrbar M.

Life Sci Alliance. 2019 Jun 3;2(3). pii: e201900304. doi: 10.26508/lsa.201900304. Print 2019 Jun.

7.

Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.

Lin PD, Cardenas A, Hauser R, Gold DR, Kleinman KP, Hivert MF, Fleisch AF, Calafat AM, Webster TF, Horton ES, Oken E.

Environ Int. 2019 Aug;129:343-353. doi: 10.1016/j.envint.2019.05.027. Epub 2019 May 28.

8.

Identification of High-Yield Targets for Antimicrobial Stewardship Program Efforts Within a Nonfreestanding Children's Hospital.

Klatte JM, Knee A, Szczerba F, Horton ER, Kopcza K, Fisher DJ.

Hosp Pediatr. 2019 May;9(5):355-364. doi: 10.1542/hpeds.2018-0254.

PMID:
31003995
9.

Assessment and selection for rehabilitation following acute stroke: a prospective cohort study in Queensland, Australia.

Grimley RS, Rosbergen IC, Gustaffson L, Horton E, Green T, Cadigan G, Cadilhac DA, Kuys S.

Clin Rehabil. 2019 Jul;33(7):1252-1263. doi: 10.1177/0269215519837585. Epub 2019 Mar 28.

PMID:
30919665
10.

Erratum. Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired glucose regulation. Diabetes Care 2017;40:1668-1677.

Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group.

Diabetes Care. 2019 Apr;42(4):701. doi: 10.2337/dc19-er04. No abstract available.

11.
12.

Opioid Use in Children.

Matson KL, Johnson PN, Tran V, Horton ER, Sterner-Allison J; Advocacy Committee on behalf of Pediatric Pharmacy Advocacy Group.

J Pediatr Pharmacol Ther. 2019 Jan-Feb;24(1):72-75. doi: 10.5863/1551-6776-24.1.72.

13.

Long-term Association of Depression Symptoms and Antidepressant Medication Use With Incident Cardiovascular Events in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Type 2 Diabetes.

Hazuda HP, Gaussoin SA, Wing RR, Yanovski SZ, Johnson KC, Coday M, Wadden TA, Horton ES, Van Dorsten B, Knowler WC; Look AHEAD Research Group.

Diabetes Care. 2019 May;42(5):910-918. doi: 10.2337/dc18-0575. Epub 2019 Mar 4.

PMID:
30833373
14.

Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity.

Cardenas A, Hauser R, Gold DR, Kleinman KP, Hivert MF, Fleisch AF, Lin PD, Calafat AM, Webster TF, Horton ES, Oken E.

JAMA Netw Open. 2018 Aug 3;1(4):e181493. doi: 10.1001/jamanetworkopen.2018.1493.

15.

Response to 'Views of oral antibiotics and advice seeking about acne: a qualitative study of online discussion forums' based on evidence obtained from The Acne Priority Setting Partnership.

Horton E, Lee N, Layton AM, Eady EA.

Br J Dermatol. 2019 May;180(5):1265-1266. doi: 10.1111/bjd.17599. Epub 2019 Jan 24. No abstract available.

PMID:
30604870
16.

Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.

Prasad K, Siemieniuk R, Hao Q, Guyatt G, O'Donnell M, Lytvyn L, Heen AF, Agoritsas T, Vandvik PO, Gorthi SP, Fisch L, Jusufovic M, Muller J, Booth B, Horton E, Fraiz A, Siemieniuk J, Fobuzi AC, Katragunta N, Rochwerg B.

BMJ. 2018 Dec 18;363:k5130. doi: 10.1136/bmj.k5130. Erratum in: BMJ. 2019 Jan 10;364:l103.

PMID:
30563885
17.

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.

Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ; CIRT Investigators.

N Engl J Med. 2019 Feb 21;380(8):752-762. doi: 10.1056/NEJMoa1809798. Epub 2018 Nov 10.

18.

The effects of exercise referral schemes in the United Kingdom in those with cardiovascular, mental health, and musculoskeletal disorders: a preliminary systematic review.

Rowley N, Mann S, Steele J, Horton E, Jimenez A.

BMC Public Health. 2018 Aug 2;18(1):949. doi: 10.1186/s12889-018-5868-9. Review.

19.

Tumor endothelial marker 8 promotes cancer progression and metastasis.

Høye AM, Tolstrup SD, Horton ER, Nicolau M, Frost H, Woo JH, Mauldin JP, Frankel AE, Cox TR, Erler JT.

Oncotarget. 2018 Jul 10;9(53):30173-30188. doi: 10.18632/oncotarget.25734. eCollection 2018 Jul 10.

20.

Notch-inducing hydrogels reveal a perivascular switch of mesenchymal stem cell fate.

Blache U, Vallmajo-Martin Q, Horton ER, Guerrero J, Djonov V, Scherberich A, Erler JT, Martin I, Snedeker JG, Milleret V, Ehrbar M.

EMBO Rep. 2018 Aug;19(8). pii: e45964. doi: 10.15252/embr.201845964. Epub 2018 Jul 2.

Supplemental Content

Loading ...
Support Center